Kezar Life Sciences, Inc.
NASDAQ:KZR
6.64 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 35.493 | 40.456 | 62.882 | 21.228 | 14.951 | 24.182 | 51.033 | 9.747 |
| Short Term Investments
| 165.879 | 236.105 | 145.473 | 119.219 | 63.255 | 83.25 | 0 | 0 |
| Cash and Short Term Investments
| 201.372 | 276.561 | 208.355 | 140.447 | 78.206 | 107.432 | 51.033 | 9.747 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 2.5 | 1.967 | 1.236 | 0 | 0 | 0 |
| Other Current Assets
| 5.578 | 9.161 | 3.299 | 4.364 | 2.926 | 2.373 | 1.293 | 0.74 |
| Total Current Assets
| 206.95 | 285.722 | 211.654 | 144.811 | 81.132 | 109.805 | 52.326 | 10.487 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 8.69 | 13.172 | 5.997 | 6.749 | 8.099 | 4.595 | 1.54 | 0.862 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0.013 | 0.013 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 5.595 | 0.674 | 0.282 | 0.282 | 0.282 | 0.282 | 0.343 | 0.062 |
| Total Non-Current Assets
| 14.285 | 13.846 | 6.279 | 7.031 | 8.381 | 4.877 | 1.896 | 0.937 |
| Total Assets
| 221.235 | 299.568 | 217.933 | 151.842 | 89.513 | 114.682 | 54.222 | 11.424 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 8.251 | 2.479 | 2.028 | 2.358 | 0.823 | 0.193 | 0.547 | 0.466 |
| Short Term Debt
| 6.024 | 5.13 | 2.398 | 2.084 | 1.8 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 3.021 | 4.218 | 0.354 | 0 | 0 |
| Other Current Liabilities
| 3.469 | 3.388 | 3.786 | 2 | 3.38 | 3.144 | 0.937 | 0.185 |
| Total Current Liabilities
| 17.744 | 10.997 | 8.212 | 6.442 | 6.003 | 3.337 | 1.484 | 0.651 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 15.921 | 18.699 | 12.845 | 8.844 | 10.928 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | -4.422 | -5.464 | 2.548 | 78.425 | 28.201 |
| Total Non-Current Liabilities
| 15.921 | 18.699 | 12.845 | 4.422 | 5.464 | 2.548 | 78.425 | 28.201 |
| Total Liabilities
| 33.665 | 29.696 | 21.057 | 10.864 | 11.467 | 5.885 | 79.909 | 28.852 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 114.682 | 77.931 | 28.176 |
| Common Stock
| 0.073 | 0.068 | 0.056 | 0.046 | 0.019 | 0.019 | 0.001 | 0.001 |
| Retained Earnings
| -350.763 | -248.893 | -180.654 | -126.024 | -84.282 | -49.195 | -26.028 | -17.511 |
| Accumulated Other Comprehensive Income/Loss
| -0.13 | -0.923 | -0.291 | -0.137 | -0.196 | -0.203 | -0.111 | -0.15 |
| Other Total Stockholders Equity
| 538.39 | 519.62 | 377.765 | 267.093 | 162.505 | 158.176 | -77.48 | -27.944 |
| Total Shareholders Equity
| 187.57 | 269.872 | 196.876 | 140.978 | 78.046 | 108.797 | -25.687 | -17.428 |
| Total Equity
| 187.57 | 269.872 | 196.876 | 140.978 | 78.046 | 108.797 | -25.687 | -17.428 |
| Total Liabilities & Shareholders Equity
| 221.235 | 299.568 | 217.933 | 151.842 | 89.513 | 114.682 | 54.222 | 11.424 |